- Mario Severino, Débora Elisa Peretti, Marjorie Bardiau, Carlo Cavaliere, Matthieu Doyen, et al.. Molecular connectivity studies in neurotransmission: a scoping review. Imaging Neuroscience, 2025, 3, ⟨10.1162/imag_a_00530⟩. ⟨hal-05573745⟩
- Antoine Verger, Matthieu Doyen, Sebastien Heyer, François Goehringer, Alexandra Bruyere, et al.. Reorganization of brain connectivity in post-COVID condition: a 18F-FDG PET study. EJNMMI Research, 2025, 15 (1), pp.28. ⟨10.1186/s13550-025-01217-7⟩. ⟨hal-05573675⟩
- Laura Rozenblum, Thomas Debroucker, Marie-Odile Habert, Marine Soret, Serge Desarnaud, et al.. Cognitive impairment and brain metabolic changes in post-acute sequelae of COVID-19. Clinical Nuclear Medicine, 2025, 50 (3), pp.e146 - e153. ⟨10.1097/rlu.0000000000005614⟩. ⟨hal-05025190⟩
- Eric Malbos, Nadège Chichery, Baptiste Borwell, Gabriel Weindel, Jordan Molitor, et al.. Virtual Reality and Relaxation for the Treatment of Generalized Anxiety Disorder: A Randomized Comparative Study with Standard Intervention. Journal of Clinical Medicine, 2025, 14 (4), pp.1351. ⟨10.3390/jcm14041351⟩. ⟨hal-05096037⟩
- Pham Minh Tuan, Mouloud Adel, Nguyen Linh Trung, Tatiana Horowitz, Ismail Burak Parlak, et al.. FDG-PET-based brain network analysis: a brief review of metabolic connectivity. EJNMMI Reports, 2025, 9 (1), pp.4. ⟨10.1186/s41824-024-00232-6⟩. ⟨hal-05573669⟩
- Igor Yakushev, Antoine Verger, Matthias Brendel, Diego Cecchin, Pablo Aguiar Fernandez, et al.. Lecanemab approval in EU: what should we be ready for?– the EANM perspective. European Journal of Nuclear Medicine and Molecular Imaging, 2025, 52 (5), pp.1607-1610. ⟨10.1007/s00259-025-07066-9⟩. ⟨hal-05573619⟩
- Antoine Verger, Nelleke Tolboom, Francesco Cicone, Susan Chang, Julia Furtner, et al.. Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standard for PET imaging of brain metastases: version 1.0. European Journal of Nuclear Medicine and Molecular Imaging, 2025, 52 (5), pp.1822-1839. ⟨10.1007/s00259-024-07038-5⟩. ⟨hal-05573650⟩
- Robin Arcani, Tatiana Horowitz, Pierre-André Jarrot, Myriam Debelle, Patrick Villani, et al.. Bilateral parotitis revealing giant cell arteritis: A case report. Joint Bone Spine, 2025, 92 (3), pp.105855. ⟨10.1016/j.jbspin.2025.105855⟩. ⟨hal-05572735⟩
- Tatiana Horowitz, Matthieu Doyen, Silvia Paola Caminiti, Igor Yakushev, Antoine Verger, et al.. Metabolic Brain PET Connectivity. PET Clinics, 2025, 20 (1), pp.1-10. ⟨10.1016/j.cpet.2024.09.014⟩. ⟨hal-05572869⟩
- Anthime Flaus, Eric Guedj, Tatiana Horowitz, Franck Semah, Antoine Verger, et al.. Brain PET Imaging in the Presurgical Evaluation of Drug-Resistant Focal Epilepsy. PET Clinics, 2025, 20 (1), pp.57-66. ⟨10.1016/j.cpet.2024.09.008⟩. ⟨hal-05572800⟩
Documents récupérés de l'archive ouverte HAL 
Publications avant 2018
• Diagnosis of Infective Endocarditis After TAVR: Value of a Multimodality Imaging Approach.
Salaun E, Sportouch L, Barral PA, Hubert S, Lavoute C, Casalta AC, Pradier J, Ouk D, Casalta JP, Lambert M, Gouriet F, Gaubert JY, Dehaene A, Jacquier A, Tessonnier L, Haentjens J, Theron A, Riberi A, Cammilleri S, Grisoli D, Jaussaud N, Collart F, Bonnet JL, Camoin L, Renard S, Cuisset T, Avierinos JF, Lepidi H, Mundler O, Raoult D, Habib G.
JACC Cardiovasc Imaging. 2017 Aug 11. pii: S1936-878X(17)30604-6. doi: 10.1016/j.jcmg.2017.05.016.
• Predictive medicine: towards a multi-parametric imaging for a personal risk stratification.
Guedj E, Cammilleri S, Verger A.
Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):196-198.
• Circulating microparticles bearing Fibrin associated with whole-body 18FDG-PET: diagnostic tools to detect paraneoplastic polymyalgia rheumatica.
Mege D, Cammilleri S, Mundler O, Dignat-George F, Dubois C, Panicot-Dubois L, Guis S.
Rheumatol Int. 2016 Aug;36(8):1099-103.
• Classic Whipple’s disease diagnosed by (18)F-fluorodeoxyglucose PET.
Lagier JC, Cammilleri S, Raoult D.
Lancet Infect Dis. 2016 Jan;16(1):130.
• Diagnostic performance of [(18)F]fluorodeoxyglucose positron emission tomography-computed tomography in cyst infection in patients with autosomal dominant polycystic kidney disease.
Bobot M, Ghez C, Gondouin B, Sallée M, Fournier PE, Burtey S, Legris T, Dussol B, Berland Y, Souteyrand P, Tessonnier L, Cammilleri S, Jourde-Chiche N.
Clin Microbiol Infect. 2016 Jan;22(1):71-77.
• Molecular imaging in the diagnosis of Alzheimer’s disease and related disorders.
Koric L, Guedj E, Habert MO, Semah F, Branger P, Payoux P, Le Jeune F; CMMR study group.
Rev Neurol (Paris). 2016 Dec;172(12):725-734.
• Functional connectivity changes differ in early and late-onset Alzheimer’s disease.
Gour N, Felician O, Didic M, Koric L, Gueriot C, Chanoine V, Confort-Gouny S, Guye M, Ceccaldi M, Ranjeva JP.
Hum Brain Mapp. 2014 Jul;35(7):2978-94.
• Determination of the unmetabolised (18)F-FDG fraction by using an extension of simplified kinetic analysis method: clinical evaluation in paragangliomas.
Barbolosi D, Hapdey S, Battini S, Faivre C, Mancini J, Pacak K, Farman-Ara B, Taïeb D.
Med Biol Eng Comput. 2016 Jan;54(1):103-11.
• Functional brain substrate of quality of life in patients with schizophrenia: A brain SPECT multidimensional analysis.
Faget-Agius C, Boyer L, Richieri R, Auquier P, Lançon C, Guedj E.
Psychiatry Res. 2016 Mar 30;249:67-75.
• Neural substrate of quality of life in patients with schizophrenia: a magnetisation transfer imaging study.
Faget-Agius C, Boyer L, Wirsich J, Ranjeva JP, Richieri R, Soulier E, Confort-Gouny S, Auquier P, Guye M, Lançon C.
Sci Rep. 2015 Dec 3;5:17650.
• Changes in dorsolateral prefrontal connectivity after rTMS in treatment-resistant depression: a brain perfusion SPECT study.
Richieri R, Jouvenoz D, Verger A, Fiat P, Boyer L, Lançon C, Guedj E.
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1051-1055.
• Added value of 18F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study.
Ceccaldi M, Jonveaux T, Verger A, Krolak-Salmon P, Houzard C, Godefroy O, Shields T, Perrotin A, Gismondi R, Bullich S, Jovalekic A, Raffa N, Pasquier F, Semah F, Dubois B, Habert MO, Wallon D, Chastan M, Payoux P; NEUUS in AD study group, Stephens A, Guedj E.
Alzheimers Dement. 2017 Nov 4. pii: S1552-5260(17)33763-9.
• Changes of metabolism and functional connectivity in late-onset deafness: Evidence from cerebral 18F-FDG-PET.
Verger A, Roman S, Chaudat RM, Felician O, Ceccaldi M, Didic M, Guedj E.
Hear Res. 2017 Sep;353:8-16.
• Is the information provided by amino acid PET radiopharmaceuticals clinically equivalent in gliomas?
Verger A, Taieb D, Guedj E.
Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1408-1410.
• IDH mutation is paradoxically associated with higher 18F-FDOPA PET uptake in diffuse grade II and grade III gliomas.
Verger A, Metellus P, Sala Q, Colin C, Bialecki E, Taieb D, Chinot O, Figarella-Branger D, Guedj E.
Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1306-1311.
• Cerebral (18)FluoroDeoxy-Glucose Positron Emission Tomography in paediatric anti N-methyl-D-aspartate receptor encephalitis: A case series.
Lagarde S, Lepine A, Caietta E, Pelletier F, Boucraut J, Chabrol B, Milh M, Guedj E.
Brain Dev. 2016 May;38(5):461-70.
• Positron emission tomography in patients with psychogenic non-epileptic seizures.
McGonigal A, Arthuis M, Micoulaud-Franchi JA, Bartolomei F, Guedj E.
Neuropsychiatr Dis Treat. 2016 Apr 5;12:777-8.
• Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
Vilgrain V, Pereira H, Assenat E, Guiu B, Ilonca AD, Pageaux GP, Sibert A, Bouattour M, Lebtahi R, Allaham W, Barraud H, Laurent V, Mathias E, Bronowicki JP, Tasu JP, Perdrisot R, Silvain C, Gerolami R, Mundler O, Seitz JF, Vidal V, Aubé C, Oberti F, Couturier O, Brenot-Rossi I, Raoul JL, Sarran A, Costentin C, Itti E, Luciani A, Adam R, Lewin M, Samuel D, Ronot M, Dinut A, Castera L, Chatellier G; SARAH Trial Group.
Lancet Oncol. 2017 Dec;18(12):1624-1636.
• Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases.
Archier A, Varoquaux A, Garrigue P, Montava M, Guerin C, Gabriel S, Beschmout E, Morange I, Fakhry N, Castinetti F, Sebag F, Barlier A, Loundou A, Guillet B, Pacak K, Taïeb D.
Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1248-57.
• Incidence of salivary side effects after radioiodine treatment using a new specifically-designed questionnaire.
Moreddu E, Baumstarck-Barrau K, Gabriel S, Fakhry N, Sebag F, Mundler O, Chossegros C, Taïeb D.
Br J Oral Maxillofac Surg. 2017 Jul;55(6):609-612.
• Virtual reality cue exposure for the relapse prevention of tobacco consumption: a study protocol for a randomized controlled trial.
Giovancarli C, Malbos E, Baumstarck K, Parola N, Pélissier MF, Lançon C, Auquier P, Boyer L.
Trials. 2016 Feb 19;17:96.
• Classification of Positron Emission Tomography Brain Images using first and second derivative features
Garali I, Adel M, Bourennane S, Guedj E.
Conference: 6th European Workshop on Visual Information Processing (EUVIP)
Location: Marseille, FRANCE Date: Oct 25-27, 2016
• Brain region of interest selection for 18FDG positrons emission tomography computer-aided image classification
Garali I, Adel M, Bourennane S, Guedj E.
Conference: International Conference on Image Processing Theory, Tools and Applications (IPTA)
Location: Paris, FRANCE Date: OCT 14-17, 2014
IRBM Volume: 37 Issue: 1 Special Issue: SI Pages: 23-30 Published: Feb 2016
• Brain region ranking for 18FDG-PET computer-aided diagnosis of Alzheimer’s disease
Garali I, Adel M, Bourennane S, Guedj E.
BIOMEDICAL SIGNAL PROCESSING AND CONTROL Volume: 27 Pages: 15-23 Published: May 2016
